Joseph Patti
Principal investigator, leads Agilvax, Inc. and INHIBITEX, INC..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$3.2MFederal grants as PI2 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $3.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 11, 2020 | NIH | SBIR Phase II A Novel Immunotherapy Targeting Cancer Stem Cells for the Treatment of Triple-Negative Breast Cancer | $1.2M | Agilvax, Inc. |
| Aug 1, 2019 | NIH | SBIR Phase II A Novel Immunotherapy Targeting Cancer Stem Cells for the Treatment of Triple-Negative Breast Cancer | $2.0M | Agilvax, Inc. |
Peer ranks
Federal funding#570
Awards as PI#1,252
Patents#273
Companies
- Agilvax, Inc.Leads (SEC Form D) · Biotech
- INHIBITEX, INC.Leads (SEC Form D)
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.